Immunophotonics, Inc. funding
Immunophotonics, Inc., a pharmaceuticals company based in St. Louis, MO, filed a Form D with the SEC on September 4, 2026 and reported $10.1M raised.
Amount raised$10.1M
Offering sizeOpen-ended
Filed with the SECSeptember 4, 2026
First saleJuly 14, 2025
IndustryPharmaceuticals
SecuritiesEquity
LocationSt. Louis, MO
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far45
Minimum investment$100K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 4